Advanced glycosylation end products, protein kinase C and renal alterations in diabetic rats

Chinese Medical Journal

Volumn 113, Issue 12, 2000, Pages 1087-1091

  Rong, Jian ^a   Qiu, Hongxin ^b   Wang, Shuping ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Aminoguanidine advanced glycosylation end products; Diabetic nephropathy; Glomerular basement membrane; Insulin; Nonenzymatic glycosylation; Protein kinase C

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; CREATININE; GLYCOSYLATED HEMOGLOBIN; GUANIDINE DERIVATIVE; INSULIN; PROTEIN KINASE C;

ANIMAL; ARTICLE; BASEMENT MEMBRANE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; GLUCOSE BLOOD LEVEL; KIDNEY; MALE; METABOLISM; PATHOLOGY; PROTEINURIA; RAT; URINE; WISTAR RAT;

ANIMALS; BASEMENT MEMBRANE; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HEMOGLOBIN A, GLYCOSYLATED; INSULIN; KIDNEY; KIDNEY GLOMERULUS; MALE; PROTEIN KINASE C; PROTEINURIA; RATS; RATS, WISTAR;

EID: 0041034603     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Xia P, Inoguchi T, Kern TS, et al. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;43: 1122-1128.
2. Copeland KR, Yatscoff RW, Thliveris JA, et al. Nonenzymatic glycation and altered renal structure and function in the diabetic rat. Kidney Int 1987;32:664-670.
3. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994;72:138-141.
4. Soulis-Liparota T, Cooper M, Papazoglou D, et al. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats. Diabetes 1991;40:1328-1331.
5. Misra RP. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 1972;58:135-139.
6. Makita Z, Vlassara H, Cerami A, et al. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992;267:5133-5138.
7. Edwards CA, O'brien WD. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 1980;104:161-165.
8. Jensen EB, Gundersen HJD, Osterby R. Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 1979;115:19-25.
9. Derubertis FR and Craven PA. Activation of protein kinase C in glomerular cells in diabetes Diabetes 1994;43:1-3.
10. Wang SP, Tang JP, Qiu HX. Determination of microproteinuria and its significance in diabetics. New Med 1989;20: 466-471.
11. Ellis EN, Good BH. Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 1991;40:1016-1022.
12. Nakamura T, Fukui M, Ebihara I, et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993;42: 450-456.